ZOVIA 1/50E-21 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zovia 1/50e-21, and when can generic versions of Zovia 1/50e-21 launch?
Zovia 1/50e-21 is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in ZOVIA 1/50E-21 is ethinyl estradiol; ethynodiol diacetate. There are twenty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; ethynodiol diacetate profile page.
Summary for ZOVIA 1/50E-21
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Patent Applications: | 48 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ZOVIA 1/50E-21 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ZOVIA 1/50E-21
US Patents and Regulatory Information for ZOVIA 1/50E-21
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | ZOVIA 1/50E-21 | ethinyl estradiol; ethynodiol diacetate | TABLET;ORAL-21 | 072722-001 | Dec 30, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |